Aune D, Feng T, Schlesinger S, Janszky I, Norat T, Riboli E. Diabetes mellitus, blood glucose and the risk of atrial fibrillation: a systematic review and meta-analysis of cohort studies. J Diabetes Complic. 2018;32(5):501–11.

Article  Google Scholar 

Cadby G, McArdle N, Briffa T, Hillman DR, Simpson L, Knuiman M, et al. Severity of OSA is an independent predictor of incident atrial fibrillation hospitalization in a large sleep-clinic cohort. Chest. 2015;148(4):945–52.

Article  Google Scholar 

Hobbelt AH, Siland JE, Geelhoed B, Van Der Harst P, Hillege HL, Van Gelder IC, et al. Clinical, biomarker, and genetic predictors of specific types of atrial fibrillation in a community-based cohort: data of the PREVEND study. Europace. 2017;19(2):226–32.

Google Scholar 

Nalliah CJ, Sanders P, Kalman JM. The impact of diet and lifestyle on atrial fibrillation. Curr Cardiol Rep. 2018;20(12):137.

Article  Google Scholar 

Lip GYH, Coca A, Kahan T, Boriani G, Manolis AS, Olsen MH, et al. Hypertension and cardiac arrhythmias: a consensus document from the European Heart Rhythm Association (EHRA) and ESC council on hypertension, endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS) and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLEACE). Europace. 2017;19(6):891–911.

Article  Google Scholar 

Calkins H, Reynolds MR, Spector P, Sondhi M, Xu Y, Martin A, et al. Treatment of atrial fibrillation with antiarrhythmic drugs or radiofrequency ablation: two systematic literature reviews and meta-analyses. Circ Arrhythm Electrophysiol. 2009;2(4):349–61.

Article  CAS  Google Scholar 

Weerasooriya R, Khairy P, Litalien J, Macle L, Hocini M, Sacher F, et al. Catheter ablation for atrial fibrillation: are results maintained at 5 years of follow-up? J Am Coll Cardiol. 2011;57(2):160–6.

Article  Google Scholar 

Ouyang F, Tilz R, Chun J, Schmidt B, Wissner E, Zerm T, et al. Long-term results of catheter ablation in paroxysmal atrial fibrillation: lessons from a 5-year follow-up. Circulation. 2010;122(23):2368–77.

Article  Google Scholar 

Steinberg JS, Palekar R, Sichrovsky T, Arshad A, Preminger M, Musat D, et al. Very long-term outcome after initially successful catheter ablation of atrial fibrillation. Heart Rhythm. 2014;11(5):771–6.

Article  Google Scholar 

Jongnarangsin K, Chugh A, Good E, Mukerji S, Dey S, Crawford T, et al. Body mass index, obstructive sleep apnea, and outcomes of catheter ablation of atrial fibrillation. J Cardiovasc Electrophysiol. 2008;19(7):668–72.

Article  Google Scholar 

Mohanty S, Mohanty P, Di Biase L, Bai R, Pump A, Santangeli P, et al. Impact of metabolic syndrome on procedural outcomes in patients with atrial fibrillation undergoing catheter ablation. J Am Coll Cardiol. 2012;59(14):1295–301.

Article  Google Scholar 

Hindricks G, Potpara T, Dagres N, Arbelo E, Bax JJ, Blomström-Lundqvist C, et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): the task force for the diagnosis and management of atrial fibrillation of the European society of cardiology (ESC) developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur Heart J. 2021;42(5):373–498.

Article  Google Scholar 

Middeldorp ME, Pathak RK, Meredith M, Mehta AB, Elliott AD, Mahajan R, et al. PREVEntion and regReSsive effect of weight-loss and risk factor modification on atrial fibrillation: the REVERSE-AF study. Europace. 2018;20(12):1929–35.

Article  Google Scholar 

Pathak RK, Middeldorp ME, Meredith M, Mehta AB, Mahajan R, Wong CX, et al. Long-term effect of goal-directed weight management in an atrial fibrillation cohort: a long-term follow-up study (LEGACY). J Am Coll Cardiol. 2015;65(20):2159–69.

Article  Google Scholar 

Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Int J Surg. 2021;88:105906.

Article  Google Scholar 

Liu X, Guo L, Xiao K, Zhu W, Liu M, Wan R, et al. The obesity paradox for outcomes in atrial fibrillation: evidence from an exposure-effect analysis of prospective studies. Obes Rev. 2020;21(3):e12970.

Article  Google Scholar 

Greenland S, Longnecker MP. Methods for trend estimation from summarized dose-response data with applications to meta-analysis. Am J Epidemiol. 1992;135(11):1301–9. https://doi.org/10.1093/oxfordjournals.aje.a116237.

Article  CAS  Google Scholar 

Xu C, Doi SAR. The robust error meta-regression method for dose–response meta-analysis. Int J Evid Based Healthcare. 2018;16(3):138–44. https://doi.org/10.1097/XEB.0000000000000132.

Article  Google Scholar 

Donnellan E, Wazni OM, Kanj M, Baranowski B, Cremer P, Harb S, et al. Association between pre-ablation bariatric surgery and atrial fibrillation recurrence in morbidly obese patients undergoing atrial fibrillation ablation. Europace. 2019;21(10):1476–83.

Article  Google Scholar 

Donnellan E, Wazni O, Kanj M, Hussein A, Baranowski B, Lindsay B, et al. Outcomes of atrial fibrillation ablation in morbidly obese patients following bariatric surgery compared with a nonobese cohort. Circ Arrhythm Electrophysiol. 2019;12(10):e007598.

Article  Google Scholar 

Gessler N, Willems S, Steven D, Aberle J, Akbulak RO, Gosau N, et al. Supervised obesity reduction trial for AF ablation patients: results from the SORT-AF trial. Europace. 2021;23(10):1548–58.

Article  Google Scholar 

Lau Y, Mackey W, Connelly D. P347 Physician-led, weight loss advice prior to atrial fibrillation ablation, overall weight change and clinical outcomes. EP Europace. 2020;22(Supplement_1):euaa162. 340.

Article  Google Scholar 

Shah F, Sherazi S, Hall B, McNitt S, Rosero S, Huang D, et al., editors. Relation of weight change to atrial fibrillation recurrence following catheter ablation. J Cardiovasc Electrophysiol; 2020: WILEY 111 RIVER ST, HOBOKEN 07030–5774, NJ USA.

Yew Ding W, Kozhuharov N, Hao Chin S, Shaw M, Snowdon R, Lip GYH, et al. Feasibility of weight loss in obese atrial fibrillation patients attending a specialist arrhythmia clinic and its impact on ablation outcomes. J Arrhythm. 2020;36(6):984–90.

Article  Google Scholar 

Mohanty S, Mohanty P, Natale V, Trivedi C, Gianni C, Burkhardt JD, et al. Impact of weight loss on ablation outcome in obese patients with longstanding persistent atrial fibrillation. J Cardiovasc Electrophysiol. 2018;29(2):246–53.

Article  Google Scholar 

Bunch TJ, May HT, Bair TL, Crandall BG, Cutler MJ, Jacobs V, et al. Long-term influence of body mass index on cardiovascular events after atrial fibrillation ablation. J Interv Card Electrophysiol. 2016;46(3):259–65.

Article  Google Scholar 

Pathak RK, Middeldorp ME, Lau DH, Mehta AB, Mahajan R, Twomey D, et al. Aggressive risk factor reduction study for atrial fibrillation and implications for the outcome of ablation: the ARREST-AF cohort study. J Am Coll Cardiol. 2014;64(21):2222–31.

Article  Google Scholar 

Wanahita N, Messerli FH, Bangalore S, Gami AS, Somers VK, Steinberg JS. Atrial fibrillation and obesity–results of a meta-analysis. Am Heart J. 2008;155(2):310–5.

Article  Google Scholar 

Wang TJ, Parise H, Levy D, D’Agostino RB Sr, Wolf PA, Vasan RS, et al. Obesity and the risk of new-onset atrial fibrillation. JAMA. 2004;292(20):2471–7.

Article  CAS  Google Scholar 

Liu M, Mei K, Liu X, Zhao Y. Impact of body mass index on procedural complications, procedure duration, and radiation dose in patients with atrial fibrillation undergoing radiofrequency ablation: a systematic review and meta-analysis. Clin Cardiol. 2020;43(10):1067–75.

Article  Google Scholar 

Patel D, Mohanty P, Di Biase L, Sanchez JE, Shaheen MH, Burkhardt JD, et al. Outcomes and complications of catheter ablation for atrial fibrillation in females. Heart Rhythm. 2010;7(2):167–72.

Article  Google Scholar 

Clamp LD, Hume DJ, Lambert EV, Kroff J. Enhanced insulin sensitivity in successful, long-term weight loss maintainers compared with matched controls with no weight loss history. Nutr Diabetes. 2017;7(6):e282.

Article  CAS  Google Scholar 

Tsalamandris S, Antonopoulos AS, Oikonomou E, Papamikroulis GA, Vogiatzi G, Papaioannou S, et al. The role of inflammation in diabetes: current concepts and future perspectives. Eur Cardiol. 2019;14(1):50–9.

Article  Google Scholar 

Nalliah CJ, Sanders P, Kottkamp H, Kalman JM. The role of obesity in atrial fibrillation. Eur Heart J. 2016;37(20):1565–72.

Article  Google Scholar 

Waranugraha Y, Rizal A, Yuniadi Y. A systematic review and meta-analysis of the direct comparison of second-generation cryoballoon ablation and contact force-sensing radiofrequency ablation in patients with paroxysmal atrial fibrillation. J Pers Med. 2022;12(2):298.

Article  Google Scholar 

Cheng X, Hu Q, Gao L, Liu J, Qin S, Zhang D. Sex-related differences in catheter ablation of atrial fibrillation: a systematic review and meta-analysis. Europace. 2019;21(10):1509–18.

Article  Google Scholar 

Asad ZUA, Yousif A, Khan MS, Al-Khatib SM, Stavrakis S. Catheter ablation versus medical therapy for atrial fibrillation: a systematic review and meta-analysis of randomized controlled trials. Circ Arrhythm Electrophysiol. 2019;12(9):e007414.

Article  Google Scholar 

Akoum N, Mahnkopf C, Kholmovski EG, Brachmann J, Marrouche NF. Age and sex differences in atrial fibrosis among patients with atrial fibrillation. Europace. 2018;20(7):1086–92.

Article  Google Scholar 

Forleo GB, Tondo C, De Luca L, Dello Russo A, Casella M, De Sanctis V, et al. Gender-related differences in catheter ablation of atrial fibrillation. Europace. 2007;9(8):613–20.

Article  Google Scholar 

Jones NR, Taylor KS, Taylor CJ, Aveyard P. Weight change and the risk of incident atrial fibrillation: a systematic review and meta-analysis. Heart. 2019;105(23):1799–805.

Article  Google Scholar 

Aldaas OM, Malladi CL, Hsu JC. Catheter ablation of atrial fibrillation in patients with heart failure. Am J Cardiol. 2019;123(1):187–95.

Article  Google Scholar 

Park DY, An S, Murthi M, Kattoor AJ, Kaur A, Ravi V, et al. Effect of weight loss on recurrence of atrial fibrillation after ablative therapy: a systematic review and meta-analysis. J Interv Card Electrophysiol. 2022. https://doi.org/10.1007/s10840-022-01168-2.

Article  Google Scholar 

Munger TM, Dong YX, Masaki M, Oh JK, Mankad SV, Borlaug BA, et al. Electrophysiological and hemodynamic characteristics associated with obesity in patients with atrial fibrillation. J Am Coll Cardiol. 2012;60(9):851–60.

Article  Google Scholar 

Ariyaratnam JP, Middeldorp M, Thomas G, Noubiap JJ, Lau D, Sanders P. Risk factor management before and after atrial fibrillation ablation. Cardiac Electrophysiol Clin. 2020;12(2):141–54.

Article  Google Scholar 

Abed HS, Wittert GA, Leong DP, Shirazi MG, Bahrami B, Middeldorp ME, et al. Effect of weight reduction and cardiometabolic risk factor management on symptom burden and severity in patients with atrial fibrillation: a randomized clinical trial. JAMA. 2013;310(19):2050–60.

Article  CAS  Google Scholar 

Jamaly S, Carlsson L, Peltonen M, Jacobson P, Sjöström L, Karason K. Bariatric surgery and the risk of new-onset atrial fibrillation in swedish obese subjects. J Am Coll Cardiol. 2016;68(23):2497–504.

Article  Google Scholar 

Staerk L, Sherer JA, Ko D, Benjamin EJ, Helm RH. Atrial fibrillation: epidemiology, pathophysiology, an